Zurich Cantonal Bank
EW icon

Zurich Cantonal Bank’s Edwards Lifesciences EW Stock Holding History

Zurich Cantonal Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-512,394
Closed -$43.7M – 2890
2025
Q4 		$43.7M Buy
+512,394
New +$42.1M 0.09% 178

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Zurich Cantonal Bank's EW Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Edwards Lifesciences (EW) in Q1 2026: 497,549 shares worth $39.8M. The stake represents 0.09% of the portfolio and ranks #192 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in EW as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in EW in Q2 2013 and has held it in 51 quarters since. The position peaked at $40.5M in Q2 2024. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Zurich Cantonal Bank held 497,549 shares of Edwards Lifesciences worth $39.8M as of Q1 2026.
  • Edwards Lifesciences was a new Zurich Cantonal Bank position in Q1 2026.
  • Edwards Lifesciences made up 0.09% of Zurich Cantonal Bank's portfolio in Q1 2026, its #192 holding.
  • Zurich Cantonal Bank first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 51 quarters since.
  • Zurich Cantonal Bank's Edwards Lifesciences position peaked at $40.5M in Q2 2024.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.